J 2012

Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications

KŘEN, Leoš, Pavel FABIAN, Ondřej SLABÝ, Andrea JANÍKOVÁ, Ondřej SOUČEK et. al.

Basic information

Original name

Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications

Authors

KŘEN, Leoš (203 Czech Republic), Pavel FABIAN (203 Czech Republic), Ondřej SLABÝ (203 Czech Republic, belonging to the institution), Andrea JANÍKOVÁ (203 Czech Republic), Ondřej SOUČEK (203 Czech Republic), Jaroslav ŠTĚRBA (203 Czech Republic), Zdenka KŘENOVÁ (203 Czech Republic), Jaroslav MICHÁLEK (203 Czech Republic, belonging to the institution) and Zdeněk KRÁL (203 Czech Republic, guarantor)

Edition

Pathology Research and Practice, Jena, Germany, Elsevier GmbH, 2012, 0344-0338

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Germany

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.213

RIV identification code

RIV/00216224:14740/12:00060138

Organization unit

Central European Institute of Technology

UT WoS

000300602900007

Keywords in English

HLA-E; Hodgkin lymphoma; Microenvironment; Clinical stage

Tags

Tags

International impact, Reviewed
Změněno: 11/4/2013 14:05, Olga Křížová

Abstract

V originále

Although the role of the non-classical human leukocyte antigen E (HLA-E) was originally thought to be limited to the development of a maternal tolerance to a semiallogeneic fetal graft, it is now known that HLA-E exerts multiple immunoregulatory functions. The significance of the presence of HLA-E in neoplastic cells and/or backround microenvironment cells in classical Hodgkin lymphoma (cHL) is not well characterized. In our study, we evaluated the presence of HLA-E in both neoplastic and background cells in 40 cases of cHL. We found HLA-E in both neoplastic and background cells. There was a positive statistical correlation between the expression of HLA-E in neoplastic cells and the clinical stage of the disease, which indicates an immune-tolerogenic property of this multiple-purpose molecule. The presence of HLA-E in background cells seems to be prognostically neutral but its significance still needs to be determined. The mechanisms regulating the immunopathology of cHL neoplastic cells with respect to the presence of these molecule deserve further studies.

Links

ED1.1.00/02.0068, research and development project
Name: CEITEC - central european institute of technology